FEBRUARY 20, 2012

Browse Categories

Notice
  • Sorry! That page cannot be found.

AUA 2009 - Bladder Cancer: Basic Research - Quantification of Sunitinib's Antitumor Effects in a Localized Orthotopic Bladder Cancer Model - Session Highlights

Tue, 28 April 2009  |  Christopher P. Evans, MD
E-mail Print

CHICAGO, IL, USA (UroToday.com) - This study reported on the effects of sunitinib on tumor growth rate, tumor volume, and vascular endothelial growth factor (VEGF) receptor (VEGFR2) expression in an orthotopic mouse bladder cancer model.




Your session will expire in 8 hours requiring you to log in each day to view content.
Share |